Home / Private raises / OrbiMed Private Investments X, LP

OrbiMed Private Investments X, LP

Private Equity Fund · New York, New York · $1.9B sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-10-16D/A (update)$1.9B$1.9B131506(b), 3(c), 3(c)(7)Fund interestsSep 30SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Sold through (placement agents)

Broker-dealerSolicited in
UBS Switzerland AG—
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATEDAll States

No sales commission reported in the latest filing.

Issuer

IndustryPooled Investment Fund
Fund typePrivate Equity Fund
LocatedNew York, New York
EntityLimited Partnership
IncorporatedDelaware, 2025
Revenue rangeNot Applicable
SEC CIK2087033

People named in the latest filing

NameRole
OrbiMed Capital GP X, LPGeneral Partner of the Issuer (the "GPLP")
OrbiMed Capital GP X LLCGeneral Partner of the GPLP (the "GPLLC")
OrbiMed Advisors LLCManaging Member of the GPLLC ("OrbiMed Advisors")
Mona AshiyaMember of OrbiMed Advisors
David P. BonitaMember of OrbiMed Advisors
Carl L. GordonMember of OrbiMed Advisors
Geoffrey C. HsuMember of OrbiMed Advisors
W. Carter NeildMember of OrbiMed Advisors
Matthew S. RizzoMember of OrbiMed Advisors
C. Scotland StevensMember of OrbiMed Advisors
Peter A. ThompsonMember of OrbiMed Advisors

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?